139 related articles for article (PubMed ID: 17108808)
1. Adding pharmacogenetics information to drug labels: lessons learned.
Haga SB; Thummel KE; Burke W
Pharmacogenet Genomics; 2006 Dec; 16(12):847-54. PubMed ID: 17108808
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 polymorphisms: are we there yet?
Perera MA; Innocenti F; Ratain MJ
Pharmacotherapy; 2008 Jun; 28(6):755-68. PubMed ID: 18503403
[TBL] [Abstract][Full Text] [Related]
3. TPMT, UGT1A1 and DPYD: genotyping to ensure safer cancer therapy?
Maitland ML; Vasisht K; Ratain MJ
Trends Pharmacol Sci; 2006 Aug; 27(8):432-7. PubMed ID: 16815558
[TBL] [Abstract][Full Text] [Related]
4. Preventing toxicity with a gene test.
Marshall E
Science; 2003 Oct; 302(5645):588-90. PubMed ID: 14576416
[No Abstract] [Full Text] [Related]
5. Searching for the Holy Grail of oncology.
Higa GM
Am J Health Syst Pharm; 2006 Nov; 63(22):2260-2. PubMed ID: 17090748
[No Abstract] [Full Text] [Related]
6. Pharmacogenetics: a tool for individualizing antineoplastic therapy.
Innocenti F; Iyer L; Ratain MJ
Clin Pharmacokinet; 2000 Nov; 39(5):315-25. PubMed ID: 11108431
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics of irinotecan: clinical perspectives on the utility of genotyping.
Innocenti F; Ratain MJ
Pharmacogenomics; 2006 Dec; 7(8):1211-21. PubMed ID: 17184208
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of anti-cancer drugs: State of the art and implementation - recommendations of the French National Network of Pharmacogenetics.
Quaranta S; Thomas F
Therapie; 2017 Apr; 72(2):205-215. PubMed ID: 28262261
[TBL] [Abstract][Full Text] [Related]
9. A Critical Evaluation of Pharmacogenetic Information in Package Inserts for Selected Drugs Marketed in India and Its Comparison With US FDA-Approved Package Inserts.
Pai SA; Kshirsagar N
J Clin Pharmacol; 2016 Oct; 56(10):1232-42. PubMed ID: 26873003
[TBL] [Abstract][Full Text] [Related]
10. Introduction.
;
Invest New Drugs; 2005 Dec; 23(6):511. PubMed ID: 16391895
[No Abstract] [Full Text] [Related]
11. Pharmacogenetic approach for cancer treatment-tailored medicine in practice.
Hasegawa Y; Ando Y; Ando M; Hashimoto N; Imaizumi K; Shimokata K
Ann N Y Acad Sci; 2006 Nov; 1086():223-32. PubMed ID: 17185519
[TBL] [Abstract][Full Text] [Related]
12. Translation of pharmacogenetic knowledge into cancer therapeutics.
Yong WP; Innocenti F
Clin Adv Hematol Oncol; 2007 Sep; 5(9):698-706. PubMed ID: 17982411
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.
Frueh FW; Amur S; Mummaneni P; Epstein RS; Aubert RE; DeLuca TM; Verbrugge RR; Burckart GJ; Lesko LJ
Pharmacotherapy; 2008 Aug; 28(8):992-8. PubMed ID: 18657016
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacogenomic approaches for prevention of drug toxicity in cancer chemotherapy].
Hasegawa Y
Gan To Kagaku Ryoho; 2003 Mar; 30(3):325-33. PubMed ID: 12669388
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics of cytotoxic drugs.
Daly AK; Hall AG
Expert Rev Anticancer Ther; 2001 Aug; 1(2):301-8. PubMed ID: 12113035
[TBL] [Abstract][Full Text] [Related]
16. Clinical evidence supporting pharmacogenomic biomarker testing provided in US Food and Drug Administration drug labels.
Wang B; Canestaro WJ; Choudhry NK
JAMA Intern Med; 2014 Dec; 174(12):1938-44. PubMed ID: 25317785
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomic biomarkers in drug labels: what do they tell us?
Tutton R
Pharmacogenomics; 2014 Feb; 15(3):297-304. PubMed ID: 24533709
[TBL] [Abstract][Full Text] [Related]
18. [SNPs associated with adverse effects].
Isomura M; Miki Y
Gan To Kagaku Ryoho; 2005 Nov; 32(12):1908-13. PubMed ID: 16282725
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomic information in the Warning section of drug labels: A comparison between labels in the United States and those in five other countries/regions.
Imatoh T; Sai K; Saito Y
J Clin Pharm Ther; 2018 Aug; 43(4):493-499. PubMed ID: 29682780
[TBL] [Abstract][Full Text] [Related]
20. Comparing cytochrome P450 pharmacogenetic information available on United States drug labels and European Union Summaries of Product Characteristics.
Reis-Pardal J; Rodrigues A; Rodrigues E; Fernandez-Llimos F
Pharmacogenomics J; 2017 Dec; 17(6):488-493. PubMed ID: 27241061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
